As you know, we're monitoring ongoing diagnostic clinical trials very closely to determine whether the condition referred to as CCSVI exists, and whether there's an association and an increased prevalence between CCSVI and patients with MS. We're monitoring that closely, not only the studies that are being carried out in Canada but also the ones in the States and international trials as well.
On November 25th, 2010. See this statement in context.